Rallybio RLYB
NASDAQ RLYB
$16.97 -0.23 (-1.35%)
As of: Oct 1, 2026 · 12:51 PM EDT

Rallybio (RLYB) Minority Interest (2020 - 2021)

Updated

Rallybio's Minority Interest was $182.03 million in Q2 2021.

Analysis

Rallybio (RLYB) Minority Interest (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rallybio 91.28 Mn 91.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 182.03 Mn
Dec 31, 2020 182.03 Mn
API Access

Rallybio Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=RLYB&period=max&api_key=YOUR_API_KEY